Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brii Biosciences

https://www.briibio.com/

Latest From Brii Biosciences

China's 'Two Sessions': Vaccines, Drugs Seen Key To Easing Restrictions Amid New Spike

The latest policies from Beijing show that the Chinese government is readying its own new vaccines and drugs for COVID-19 in a bid to gradually ease some of the strictest pandemic restrictions globally, but progress is mixed and domestic reported infections are surging to their highest level since March 2020.

Coronavirus COVID-19 Policy

How Paxlovid Approval May Influence China's Pandemic Policies

In a surprise move, China has conditionally approved Pfizer’s oral COVID-19 antiviral Paxlovid, a development that may have far-reaching consequences for the country's pandemic policies and domestic drug developers. 

China Approvals

Olympics Foreshadow Beijing's Intention To Follow Own Policy Path?

The Beijing Winter Olympics highlight a changing China that is becoming more confident and confrontational in its policies, although a willingness to challenge international rules could potentially stall the further introductions of novel vaccines and treatments at a critical juncture of the pandemic.

China Policy

Winter Olympics Test China's 'Zero COVID' Limits, Treatment Constraints

Amid China’s increasingly inward-looking and dual circulation economic policies, the Beijing Winter Olympics provide rare insight into policymakers’ handling of a global event.

China Coronavirus COVID-19
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Brii Biosciences Limited
UsernamePublicRestriction

Register